Ventricular Dysfunction, Left
"Ventricular Dysfunction, Left" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Descriptor ID |
D018487
|
| MeSH Number(s) |
C14.280.945.900
|
| Concept/Terms |
Ventricular Dysfunction, Left- Ventricular Dysfunction, Left
- Left Ventricular Dysfunction
- Dysfunction, Left Ventricular
- Dysfunctions, Left Ventricular
- Left Ventricular Dysfunctions
- Ventricular Dysfunctions, Left
|
Below are MeSH descriptors whose meaning is more general than "Ventricular Dysfunction, Left".
Below are MeSH descriptors whose meaning is more specific than "Ventricular Dysfunction, Left".
This graph shows the total number of publications written about "Ventricular Dysfunction, Left" by people in this website by year, and whether "Ventricular Dysfunction, Left" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2016 | 6 | 1 | 7 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ventricular Dysfunction, Left" by people in Profiles.
-
Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction. Am J Cardiol. 2023 01 15; 187:84-92.
-
Trastuzumab-induced cardiac toxicity: Is serial assessment of left ventricular ejection fraction during treatment necessary? Breast J. 2020 05; 26(5):1085-1086.
-
Risk factors for longitudinal changes in left ventricular diastolic function among women and men. Heart. 2019 09; 105(18):1414-1422.
-
Use of Speckle Tracking Echocardiography to Assess Left Ventricular Systolic Function in Patients with Surgically Repaired Tetralogy of Fallot: Global and Segmental Assessment. Pediatr Cardiol. 2018 Dec; 39(8):1669-1675.
-
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. Circ Res. 2017 Jan 20; 120(2):324-331.
-
Cardiovascular Monitoring With Trastuzumab Therapy: How Frequent Is Too Frequent? JAMA Oncol. 2016 Sep 01; 2(9):1123-4.
-
Continuing Medical Education activity in Echocardiography : September 2016. Echocardiography. 2016 Sep; 33(9):1353.
-
The Use of Speckle Tracking Echocardiography for Early Detection of Myocardial Dysfunction in Patients with Duchenne Muscular Dystrophy. Pediatr Cardiol. 2016 Dec; 37(8):1422-1428.
-
Longitudinal systolic strain profiles and outcomes in peripartum cardiomyopathy. Echocardiography. 2016 Sep; 33(9):1354-60.
-
Impact of Diastolic Function Parameters on the Risk for Left Atrial Appendage Thrombus in Patients with Nonvalvular Atrial Fibrillation: A Prospective Study. J Am Soc Echocardiogr. 2016 06; 29(6):545-53.